We can readily understand why investors are attracted to unprofitable companies. By way of example, Prescient Therapeutics (ASX:PTX) has seen its share price rise 157% over the last year, delighting many shareholders. Nonetheless, only a fool would ignore…
We Think Prescient Therapeutics (ASX:PTX) Can Easily Afford To Drive Business Growth
Share this article
More News






The Stock Will Hit $150 on This Date
June 30, 2026

Expect More Crypto Volatility Ahead, Warns Jefferies
June 30, 2026